These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9616537)

  • 1. Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care.
    Price DB; Appleby JL
    Respir Med; 1998 Feb; 92(2):351-3. PubMed ID: 9616537
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
    Volmer T; Kielhorn A; Weber HH; Wiessmann KJ
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P
    Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
    Levy ML; Stevenson C; Maslen T
    Thorax; 1996 Nov; 51(11):1087-92. PubMed ID: 8958890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A; Adkins JC
    Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
    Menendez R; Stanford RH; Edwards L; Kalberg C; Rickard K
    Pharmacoeconomics; 2001; 19(8):865-74. PubMed ID: 11596838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC; Thwaites RM; Price MJ
    Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma.
    Fairfax AJ
    Respir Med; 2000 Sep; 94 Suppl D():S31-6. PubMed ID: 11003173
    [No Abstract]   [Full Text] [Related]  

  • 13. Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation.
    Wan Yau Ming S; Haughney J; Small I; Wolfe S; Hamill J; Gruffydd-Jones K; Daly C; Soriano JB; Gardener E; Skinner D; Stagno d'Alcontres M; Price DB
    Respir Med; 2017 Aug; 129():199-206. PubMed ID: 28732831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of cost evaluation in the treatment of asthma].
    Sorli J
    Med Arh; 1999; 53(3 Suppl 1):15-7. PubMed ID: 10546462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.
    van den Boom G; Rutten-van Mölken MP; Molema J; Tirimanna PR; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Dec; 164(11):2057-66. PubMed ID: 11739135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
    Orsini L; Limpa-Amara S; Crown WH; Stanford RH; Kamal K
    Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
    Armstrong EP; Malone DC
    Pharmacotherapy; 2002 Sep; 22(9):1117-23. PubMed ID: 12222547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
    Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):181-9. PubMed ID: 16136769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
    Stempel DA; Mauskopf J; McLaughlin T; Yazdani C; Stanford RH
    Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.